Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...

Sanfilippo syndrome is a rare genetic disorder that has been dubbed 'childhood Alzheimer's' because it causes children to ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Applies TAAP and MPAR Technology to Produce Novel OUD Treatments ~ ~ Prioritizes Safety and Tolerability for OUD Patients ~ SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 /Ensysce Biosciences, Inc.

It was a packed house at Yee-Haw Brewing in North Knoxville as hundreds gathered to show their support for the Begbie family and others who have children with Sanfilippo Syndrome.

A powerful editorial published today in Brain Medicine raises alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common ...

A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...

An editorial published in Brain Medicine reveals that many widely prescribed medications may disrupt sterol biosynthesis—an essential process for brain development—potentially causing harm similar to ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.

Parenteral nutrition (PN) is lifesaving for patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may lead to complications including hepatosteatosis and ...